Luciano Nicosia, PhD^1*, Gary J Spencer, PhD^1*, Nigel Brooks, PhD^2*, Fabio Amaral, PhD^1*, Naseer Basma^1*, John Chadwick, PhD, MD^1*, Bradley Revell^1*, Bettina Wingelhofer, PhD^1*, Alba Maiques-Diaz, PhD^1*, Filippo Ciceri, Ph.D.^1*, Daniel H Wiseman, PhD, MB, ChB, MRCP, FRCPath^3*, Neil A Pegg^2*, William West, PhD, MSc, MBA^2*, Tomasz Knurowski, PhD, MD^2*, Kris Frese, PhD^2*, Karen Clegg, PhD^2*, Victoria Louise Campbell, BSc, FRCPath, MBBS, MRCP^4*, Mhairi Copland, PhD, MBBChir, FRCP, FRCPath⁵, Emma Searle^6* and Tim C.P Somervaille, PhD FRCP FRCPath¹

¹Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom
²CellCentric Ltd, Cambridge, United Kingdom
³Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom
⁴Western General Hospital, Edinburgh, GBR
⁵Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, Gartnavel General Hospital, Glasgow, United Kingdom
⁶The Christie Hospital, University of Manchester, Manchester, United Kingdom

Tomohiro Yabushita, MD PhD^1,2*, Takumi Chinen, PhD^3*, Atsuya Nishiyama, PhD^4*, Shuhei Asada, MD PhD^1*, Keita Yamamoto, MD PhD^2*, Naru Sato, MD PhD^1*, Yutaka Enomoto, PhD^1*, Yosuke Tanaka, PhD^1*, Keiko Katoh, PhD^5*, Kaori Saitoh, PhD^5*, Takamasa Ishikawa, PhD^5*, Hitoshi Sato, PhD^6*, Tomoyoshi Soga, PhD^5*, Yasuhito Nannya, M.D., Ph.D.⁷, Makoto Nakanishi, MD PhD^4*, Daiju Kitagawa, PhD^3*, Toshio Kitamura, MD PhD¹ and Susumu Goyama, MD PhD^2*

¹Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
²Division of Molecular Oncology, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
³Department of Physiological Chemistry, Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan
⁴Division of Cancer Cell Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁵Institute for Advanced Biosciences, Keio University, Yamagata, Japan
⁶Division of Medical Genome Sciences, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
⁷Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo, Tokyo, Japan

Lindsey Savoy^1*, Daniel Bottomly^2*, Reid Chen^3*, Basil Allen^3*, Jeffrey W. Tyner⁴, Shannon K. McWeeney, PhD^5* and Haijiao Zhang, MD¹

¹Division of Oncological Sciences, Oregon Health & Science University, Portland, OR
²Knight Cancer Institute, Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR
³Division of Oncological Science, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁴Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR
⁵Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR

Guo Qiu^1*, Xi Xu^2* and Qifa Liu, MD³

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, CA, China
²Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
³Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Naomi Kawashima, MD, PhD^1*, Dongxu Jiang, PhD^1*, Divya Jyoti Singh, PhD^1*, Dale Grabowski, BS^1*, Carmelo Gurnari, MD^1,2*, Yasuo Kubota, MD, PhD^1*, Mai Aly, MD, BSc, MS^1*, Valeria Visconte, PhD¹, Brittany L Griffin, MS, PhD^3*, Torsten Haferlach, MD⁴, Jaroslaw P. Maciejewski, MD, PhD, FACP¹ and Babal K. Jha, PhD, MPhil, MSc, BSc^1,5*

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
³Center for Personalized Genetic Healthcare, Cleveland Clinic Foundation, Cleveland, OH
⁴MLL Munich Leukemia Laboratory, Munich, Germany
⁵Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH

Hiroki Akiyama, MD, PhD^1*, Ran Zhao, MS^1*, Yuki Nishida, MD, PhD¹, Natalia Baran, MD, PhD¹, Ziyi Li, PhD^2*, Lauren B Ostermann^1*, Po Yee Mak^1*, Edward Ayoub, PhD^1*, Sujan Piya, PhD³, Bing Z Carter, PhD¹, Michael Andreeff, MD, PhD¹ and Jo Ishizawa, MD, PhD¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Pearland, TX

Jeremy T Baeten, PhD¹, Sumedha Agashe, PhD^1*, Annabel Quinet, PhD^2*, Kimberly B. Johansson, BA^1,3, Alessandro Vindigni, PhD^1*, Geoffrey L. Uy, MD¹ and Daniel C. Link, MD¹

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
²Université de Paris and Université Paris-Saclay, INSERM, iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, Fontenay-aux-Roses, France
³Medical Scientist Training Program, Washington University in St. Louis, Saint Louis, MO

Priyanka Sharma, PhD¹, Sujan Piya, PhD^2,3, Natalia Baran, MD, PhD⁴, Anna Zal^5*, Christopher J. Hindley, PhD^6*, Kim-Hien Dao, DO⁷, Martin Sims, PhD^6*, Tomasz Zal, PhD^4,5*, Vivian Ruvolo, MS^4*, Michael Andreeff, MD, PhD⁴ and Gautam Borthakur, MD⁴

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Pearland, TX
³Division of Pathology and Laboratory Medicine Clinical Trial Operation, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Astex Pharmaceuticals, Cambridge, United Kingdom
⁷Astex Pharmaceuticals, Inc., Pleasanton, CA

Sarah Skuli, MD, PhD¹, A'Ishah Bakayoko, BA^1*, Bryan Manning, BS^1*, Gerald Wertheim, MD, PhD^1,2, Jimmy Xu, PhD^3*, Eva Nee^3*, Lorelai Mesaros^3*, Ryan Hausler, MS^1*, Manuela Lavorato, PhD^4,5*, Eiko Ogiso, PhD^4,5*, Marni Falk, MD^4,5*, Kara N. Maxwell, MD, PhD^1*, Nicolas Skuli, PhD^1*, Clementina Mesaros, PhD^3* and Martin P. Carroll, MD¹

¹Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
²Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA
³Department of Pharmacology, The University of Pennsylvania, Philadelphia, PA
⁴Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA
⁵The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA

Isabel Weinhaeuser, PhD^1*, Diego Pereira-Martins, PhD^2*, Jacobien R Hilberink, BSc^3*, Emanuele Ammatuna, MD. PhD^2*, Gerwin A. Huls, MD, PhD⁴, Eduardo M Rego, MD, PhD^5,6,7,8,9 and Jan Jacob Schuringa, PhD²

¹Experimental Hematology, University Medical Center Groningen, Groningen, AL, Netherlands
²Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
³Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
⁴University Medical Center, University Groningen, Groningen, GZ, Netherlands
⁵Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
⁶Medical Research Laboratory on Molecular Hematology (LIM-31), University of São Paulo, São Paulo, São Paulo, Brazil
⁷Center for Cell-based Therapy and Regional Hemotherapy Center, University of Sao Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Sao Paulo, Brazil
⁸University of Sao Paulo, Sao Paulo, Brazil
⁹University of São Paulo Medical School, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil

Dilan Anil Patel, MD¹, Ezhilarasi Chendamarai, PhD^2*, Julie K. Ritchey^3*, Michael P. Rettig, PhD², Leah Gehrs^2*, Paul Moore, PhD^4*, Ralph F. Alderson, PhD⁴, Ezio Bonvini, MD⁵, Matthew Christopher, MD, PhD^6* and John F. DiPersio, MD, PhD³

¹Washington University in St. Louis School of Medicine, St Louis, MO
²Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
³Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴MacroGenics, Inc., Rockville, MD
⁵MacroGenics, Rockville, MD
⁶Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Hui Zeng, MD, PhD^*, Xinya Jiang^*, Juan Du^*, Lei Hua^*, Xiaofan Sun^* and Fangshu Liu^*

The First Affiliated Hospital of Jinan University, Guangzhou, China

Heather Ogana¹, Samantha Hurwitz¹, Zesheng Wan, PhD^1*, Hye Na Kim, PhD^1*, Samy Jambon, PhD^2*, Hisham Abdel-Azim, MD^3*, Miller Huang, PhD^1*, Moghimi Babak, MD^2*, Nora Heisterkamp, PhD^4*, Anne-Marie Carbonell, MD^5*, Chintan Parekh, MBBS¹, Marina Konopleva, MD, PhD^6,7, Deepa Bhojwani, MD⁸ and Yong-Mi Kim, MD, PhD, MPH¹

¹Division of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA
²Division of of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA
³Division of Hematology and Oncology, Department of Pediatrics, Loma Linda University, Loma Linda, CA
⁴City of Hope Comprehensive Cancer Center, Monrovia, CA
⁵Oncosynergy, Stamford, CT
⁶MD Anderson Cancer Center, Houston, TX
⁷Albert Einstein College of Medicine, Bronx, NY
⁸Children's Hospital of Los Angeles, Los Angeles, CA

Kanwal Mahmood, MS^1*, Neetu Dayal, PhD^2*, Dominique R Bollino^1*, Herman O Sintim, PhD^2* and Ashkan Emadi, MD, PhD¹

¹University of Maryland School of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²Department of Chemistry and Center for Drug Discovery, Purdue University, West Lafayette, IN

Bon-Kwan Koo, MA^1*, Je-Hwan Lee, MD, PhD¹, Eun-Ji Choi, M.D.², Eun-Hye Hur, PhD^1*, Ju Hyun Moon, MA^1*, Ji Yun Kim, MA^1*, Han-Seung Park, MD^1*, Yunsuk Choi, MD^1*, Jung-Hee Lee, MD, PhD^1*, Kyoo Hyung Lee, MD, PhD^1* and Jinhwan Kim^3*

¹Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Asan Medical Center, Seoul, Korea, Republic of (South)
³R&D Institute, Yungjin Pharmaceutical Co., Gyeonggi-do, Korea, Republic of (South)

Ishnoor Sidhu, PhD^1,2*, Sonali P. Barwe, PhD, MSc^1,2, Kristi Lynn Kiick, Ph.D^2*, E. Anders Kolb, MD¹ and Anilkumar Gopalakrishnapillai, PhD, MSc^1,2

¹Nemours Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE
²University of Delaware, Newark, DE

Warren C. Fiskus, BSc, PhD¹, Kaberi Das^2*, Christopher Peter Mill, PhD, BA³, Christine E Birdwell, PhD^4*, John A. Davis^4*, Kevin Philip^4*, Noor Alhamadani^4*, Tapan M. Kadia, MD⁵, Naval Daver, MD⁵, Koji Sasaki, MD⁵, Koichi Takahashi, MD, PhD⁶, Sanam Loghavi, MD⁷, Courtney D. DiNardo, MD, MSCE⁵, Jesse Vargas, PhD⁸ and Kapil N. Bhalla, MD⁵

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²UT MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Cleave Therapeutics, Inc., San Diego, CA

Dominique R Bollino^*, J Preston Claiborne, MD^*, Kanwal Mahmood, MS^*, Xinrong Ma, PhD^*, Kayla M Tighe, BS^*, Brandon Cooper^*, Rena G. Lapidus, PhD^*, Erin T Strovel, PhD^* and Ashkan Emadi, MD, PhD

University of Maryland School of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

Md. Hafiz Uddin^1*, Amro Aboukameel, MS^1*, Husain Khan^1*, Sahar Bannoura^1*, Yiwei Li^1*, Abhinav Deol, MD¹, Jay Yang, MD², Asfar Sohail Azmi, PhD^1*, Jaroslaw P. Maciejewski, MD, PhD, FACP³ and Suresh Kumar Balasubramanian, MD^1,4

¹Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
²Department of Oncology, Wayne State University, Detroit, MI
³Translational Hematology and Oncology Research, Cleveland Clinic Foundation/ Taussig Cancer Institute, Cleveland, OH
⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Dominique Sternadt, MSc^1*, Diego Pereira-Martins, PhD^1*, Douglas RA Silveira, MD^2*, Prodromos Chatzikyriakou, PhD^3*, Maria del Pilar Casares Alaez^3*, Isabel Weinhaeuser, PhD^4*, Shanna M Hogeling, MSc^1*, Emanuele Ammatuna, MD. PhD^1*, Gerwin A. Huls, MD, PhD¹, Lynn Quek, MBBCh, DPhil, MRCP (UK), FRCPath^3* and Jan Jacob Schuringa, PhD¹

¹Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
²School of Cancer and Pharmaceutical Sciences, King's College London, London, ENG, United Kingdom
³School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
⁴Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, AL, Netherlands

Nanni Schmitt, MSc^1*, Jana-Julia Siegler^2*, Lena Wagner^2*, Nicole Schulze^2*, Alexandra Beck^1*, Wolf-Karsten Hofmann, MD¹, Torsten Haneke, PhD^2*, Uwe Reusch, PhD^2*, José Medina-Echeverz^2*, Jan Endell^2*, Thorsten Ross, PhD^2*, Christian Merz, PhD^2* and Daniel Nowak, MD^1*

¹Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
²Affimed GmbH, Heidelberg, Germany

Sonali P. Barwe, PhD, MSc¹, Yana Pikman, MD², E. Anders Kolb, MD¹ and Anilkumar Gopalakrishnapillai, PhD, MSc¹

¹Nemours Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE
²Dana Farber Cancer Institute, Boston, MA

Warren C. Fiskus, BSc, PhD¹, Jessica Piel, PhD^2*, Murphy Hentemann, PhD^2*, Christopher Peter Mill, PhD, BA³, Christine E Birdwell, PhD^4*, Kaberi Das^5*, John A. Davis^4*, Noor Alhamadani^4*, Kevin Philip^4*, Tapan M. Kadia, MD⁶, Naval Daver, MD⁷, Sanam Loghavi, MD⁸, Courtney D. DiNardo, MD, MSCE⁷ and Kapil N. Bhalla, MD⁷

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Foghorn Therapeutics, Cambridge, MA
³MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵UT MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Zhijian Xiao, MD&PhD^1*, Chunkang Chang^2*, Qiubai Li^3*, Xiaojing Yan, MD, PhD⁴, Tiejun Qin^5*, Hongyan Tong, MD^6*, Yu Zhang^7*, Min Dai^7*, Yanjie He, MD & PhD^8*, Jianyu Weng^9*, Jian Li, MD¹⁰, Sujun Gao, MD^11*, Rong Fu, PhD^12*, Xudong Wei, PhD¹³, Aili He^14*, Jinhai Ren, MD^15*, Tong Wu, MD¹⁶, Xin Du^17*, Yanni Zhang, PhD^18*, Ke Xu^18*, Zhengyi Wang, PhD^18*, Michelle Yang, MD^18* and Andrew Zhu^18*

¹MDS and MPN Centre, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Department of Hematology, Shanghai Sixth People's Hospital, Shanghai, China
³Department of Hematology, Union Hospital affiliated to Tongji Medical, College of Huazhong University of Science and Technology, Wuhan, CHN
⁴Department of Hematology, First Hospital of China Medical University, Shenyang, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁷Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁸Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
⁹Guangdong Provincial People’s Hospital, Guangdong, China
¹⁰Department of Hematopathology, Peking Union Medical College Hospital, Beijing, China
¹¹Department of Hematology, The First Hospital of Jilin University, Changchun, China
¹²Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
¹³Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
¹⁴Department of Hematology, Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital）, Xi'an, China
¹⁵Department of Hematology, The Second Hospital of HeBei Medical University, Shijiazhuang, China
¹⁶Department of Hematology, Beijing GoBroad Boren Hospital, Beijing, China
¹⁷Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, CA, China
¹⁸I-Mab Biopharma, Shanghai, China

Pavla Koralkova^1*, Nikola Niederlova^1*, Iveta Hradilova^1*, Jan Gursky, PhD^1*, Barbora Cudova^2*, Helena Urbankova, Dr., PhD.^2*, Eva Reznickova^3*, Tomas Gucky^3*, Denisa Myslivcova, RNDr., PhD.^4*, Monika Belickova, PhD^5*, Vladimir Krystof^3* and Vladimir Divoky, PhD¹

¹Department of Biology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
²Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
³Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Olomouc, Czech Republic
⁴Institute of Hematology and Blood Transfusion, Prague, Czech Republic
⁵Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Azadeh Hajmirza, PhD^1*, Laura Simon, PhD^1*, Jalila Chagraoui, PhD^1*, Nadine Mayotte^1*, Jean-François Spinella, PhD^1*, Tara Macrae^1*, Bernhard Lehnertz, Ph.D.^1*, Thierry Bertomeu, Ph.D.^1*, Jasmin Coulombe-Huntington, Ph.D.^1*, Geneviève Boucher^1*, Sébastien Lemieux, Ph.D.^2*, Mike Tyers, Ph.D.^1*, Josee Hebert, MD^3,4,5,6 and Guy Sauvageau, MD, PhD^7,8,9,10,11

¹Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada
²Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada
³Department of Medicine, Université de Montréal, Montreal, QC, Canada
⁴The Leucegene Project at the Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
⁵Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
⁶Hôpital Maisonneuve-Rosemont, Département d’Hématologie-Oncologie, Montréal, QC, Canada
⁷Banque de Cellules Leucemiques du Quebec, Centre de Recherche de l’Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
⁸Division of Hematology and Hematopoietic Stem Cell Transplant Program, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
⁹The Leucegene Project at the Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada
¹⁰Projet Leucegene, Institut de Recherche en Immunologie et en Cancerologie (IRIC), Universite de Montreal, Montreal, QC, Canada
¹¹The Leucegene Project at the Institute for Research in Immunology and Cancer (IRIC), Montréal, QC, Canada, Montréal, QC, Canada